Viral ‘Molecule’ Pill Sparks Health Crisis Among Russian Teens

Moscow– A dangerously addictive weight-loss pill dubbed “Molecule” is surging in popularity among Russian teenagers, fueled by TikTok influencers and black-market sales, leading to a wave of hospitalizations and urgent calls for a nationwide ban.

Promoted as a “miracle” slimming aid, the unregulated capsules—sold for as little as 200 rubles ($2) per pack on Telegram channels—promise rapid fat loss without diet or exercise. Recent lab tests by Russian health authorities have confirmed the pills contain sibutramine, a banned appetite suppressant pulled from global markets in 2010 over links to heart attacks and strokes, alongside unlisted stimulants like caffeine and ephedrine.  Users as young as 14 report severe side effects, including palpitations, nausea, insomnia, and fainting, with emergency room visits among adolescents spiking 30% in major cities like Moscow and St. Petersburg over the past month.
Twenty-two-year-old Maria Ivanovna, a former user from Yekaterinburg, shared her ordeal with the BBC: “I lost 10 kilos in two weeks, but then my heart started racing so fast I blacked out. It’s not worth it—doctors say it could have killed me.” Experts warn the drug’s low cost and viral hype, amplified by influencers flaunting “before-and-after” transformations, exploit body image insecurities amid Russia’s rising youth obesity rates.
Russia’s Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor) has launched raids on illicit sellers, seizing thousands of packets, but the underground trade persists. Pediatrician Dr. Elena Petrova told state media: “This is a ticking time bomb for our youth—addiction risks and organ damage could scar a generation.”

As awareness grows, social media campaigns urge teens to #DitchMolecule, but officials say stricter platform regulations are needed to curb the spread. With winter holidays approaching, health advocates fear a fresh surge in misuse.

Related Posts

Multi-State Supply Chain of Fake RituxiRel and Alburel Injections Exposed Amid Health Risks

Pune— In a major breakthrough exposing vulnerabilities in India’s pharmaceutical supply chain, the Food and Drug Administration (FDA) Pune Division has declared batches of “RituxiRel” (a counterfeit version of Rituximab,…

TN, Karnataka, Rajasthan declare highest number of NSQs in January

New Delhi:  Around 29% of the total Not of Standard Quality (NSQ) drug samples reported by the State drug testing laboratories in the month of January were collected and tested…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Multi-State Supply Chain of Fake RituxiRel and Alburel Injections Exposed Amid Health Risks

Multi-State Supply Chain of Fake RituxiRel and Alburel Injections Exposed Amid Health Risks

TN, Karnataka, Rajasthan declare highest number of NSQs in January

TN, Karnataka, Rajasthan declare highest number of NSQs in January

Centre reorganises CDSCO Zone Baddi amid Drug Quality Concerns

Centre reorganises CDSCO Zone Baddi amid Drug Quality Concerns

CDSCO modifies norms for testing permissions to speed up drug approvals

CDSCO modifies norms for testing permissions to speed up drug approvals

British men jailed for smuggling cocaine into Bali

British men jailed for smuggling cocaine into Bali

Andhra milk adulteration: Four dead, seven in critical condition

Andhra milk adulteration: Four dead, seven in critical condition